Cosmetic Breast Surgery

New Patient Appointment or 214-645-2353

The plastic surgeons at UT Southwestern Medical Center are not only trained in the latest breast surgery innovations, we’re also developing them here in Dallas and Frisco.

Patients can count on us for effective solutions, whether they want to change the size and shape of their breasts for cosmetic reasons or they need breast reconstruction surgery after cancer treatment.

What is Cosmetic Breast Surgery?

Cosmetic breast surgery encompasses a variety of procedures designed to enhance or modify the appearance of the breasts. These procedures can include breast augmentation, breast reduction, breast lift (mastopexy), or a combination of these, depending on individual goals and concerns.

Whether seeking to enhance, reduce, or rejuvenate, breast plastic surgery offers personalized solutions to achieve the desired aesthetic outcome. This field of plastic surgery empowers individuals to make choices that align with their unique preferences, ultimately fostering confidence and satisfaction with their breast appearance.

Leading-Edge Breast Surgery Techniques

UT Southwestern has been at the forefront of developments in breast surgery procedures, such as investigating implants, establishing new surgical procedures, and using 3-D technology as a tool when working with patients.

Cosmetic Breast Surgery Procedures we Offer:

All our surgeons have completed extensive training in plastic surgery, studying for an additional six to nine years after completing their medical school education. Most of our surgeons have passed rigorous written and oral exams to become board certified by the American Board of Plastic Surgery.

Our faculty members have authored thousands of scientific publications, we teach the next generation of plastic surgeons how to perform procedures, and we conduct extensive research on new technology, materials, and breast surgery techniques.

Important Information for Women with Breast Implants

Breast implant illness

Of the 1% of women who experience complications after having breast implants, a small number develop a series of nonspecific and somewhat vague symptoms collectively known as breast implant illness (BII).

BII is not a formal diagnosis, and researchers are still working to understand how it develops and if it is related to the presence of breast implants. The most commonly reported symptoms are anxiety, depression, brain fog, chronic fatigue, dry mouth, dry eyes, gastrointestinal distress, hair loss, headaches, joint or muscle pain, skin problems, and significant changes in weight.

Unfortunately, increased awareness of BII has become a double-edged sword. Women experiencing its symptoms may feel comfort in knowing they are not alone but also be vulnerable to misinformation currently circulating about the illness.

It’s important for women with breast implants to understand that experiencing symptoms of BII does not necessarily mean that they will need to have their implants removed. Often other conditions – such as autoimmune or hormonal disorders – cause similar symptoms, so it can initially be challenging to locate the root cause.

Breast implant patients should rest assured that only a small percentage of breast implants result in complications and even fewer in conditions that require implant removal. If you are experiencing problems after breast implant surgery and suspect that they may be related to BII, contact your plastic surgeon and care team for an evaluation.

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)

On March 23, 2017, the U.S. Food and Drug Administration (FDA) issued a press release regarding a rare disorder linked to breast implants: It’s a type of non-Hodgkin lymphoma and is called breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).

Here’s what patients need to know:

There have been approximately 384 cases of BIA-ALCL in the U.S. associated with breast implants (out of hundreds of thousands of cosmetic and reconstructive procedures, many of which involved multiple surgeries).
BIA-ALCL is not breast cancer but rather a form of a lymphoproliferative disorder (lymphoma) that is very similar to cutaneous ALCL.
The majority of cases reported have been in textured-surface breast implants. There are 28 cases reported with smooth implants, but most of those patients had a textured-surface implant or tissue expander at one point.
Women with breast implants have a low but increased risk of developing this condition compared with women without breast implants.
Most women with BIA-ALCL come in with late-onset (more than 5 years after placement) fluid collection around the implant.
The majority of cases are treated by removal of the implant and capsule surrounding the implant, which cures the condition.

In summary:

Women should be reassured that BIA-ALCL is very rare and very treatable should it occur.
The condition seems to be associated with textured-surface implants.
Women should not alter their routine medical care and follow-up.
Removal of implants in women without symptoms is not recommended.

Patients who have questions should contact their plastic surgeon. We’re happy to see patients with concerns or questions.